Autopsy report · NCT00792506

Phase II Clinical Trial of ITF2357 In Patients With Relapsed/Refractory Multiple Myeloma

“The study was prematurely discontinued for lack of recruitement.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 1 year 9 months before it stopped.
• 1 participant enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Italfarmaco

Sponsor type

Industry

Conditions

Multiple Myeloma

Interventions

ITF2357

Participants

1

Sites

1

Countries

Italy

Trials that died the same way

• To Determine the Objective Response Rate of 4 Cycles of Docetaxel + Anthracycline (Epirubicin or Doxorubicine) Followed by 4 Cycles of Docetaxel Single Agent
  “the study was early terminated due to lack of recruitment.” (88% match in meaning)
• Comparing Palliative Radiotherapy With or Without Carboplatin
  “The study was stopped due to insufficient recruitment.” (85% match in meaning)
• Biliary Interventions in Critically Ill Patients With Secondary Sclerosing Cholangitis (BISCIT)
  “Study was stopped due to insufficient recruitment.” (84% match in meaning)
• Study to Compare the Efficacy and Safety of Micafungin Versus Conventional Amphotericin B for the Treatment of Neonatal Candidiasis
  “It was decided to discontinue the study due to insufficient recruitment.” (83% match in meaning)
• Safety, Tolerability and Efficacy of AVP-786 for the Treatment of Disinhibition
  “The study was terminated prematurely because of difficulty with recruiting.” (83% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.